Wednesday, 27 June 2012

12 Agriculture, Tech, Consumer Discretionary And Health Care Stocks That Will Lead The Market Rebound


Gene Peroni, Senior Vice President, Equity Research, Advisors Asset Management
Gene Peroni: My background is in the area of technical analysis. Over the years we determined that our technical analysis approach was useful not just for short-term traders but for those looking to identify those stocks that could be bought and held over a longer period of time. In 1995 I made the transition from research to portfolio management, initially with unit investment trusts, which are static portfolios that are chosen for a specified length of time. So my comments should be seen as technically-driven, based on what we are observing in terms of trends in the market.
Our bottom-up approach includes price architecture, net money flow behavior — mostly on the part of the non-institutional or non-reactive participants — and, finally, relative strength.  We begin by identifying attractive individual stocks and then noting the concentrations of attractive stocks. That leads us to what sectors look most promising.
If, as we update and study our charts on an ongoing basis, we see, for instance, that Boeing looks attractive and Northrup and Lockheed Martin also look attractive, we might make a case that aerospace and defense should be part of our overall strategically-diversified portfolio. We will also include other sectors where there are the greatest depths of attractive individual stocks.
Wally Forbes: That sounds very interesting. It goes above and beyond the more standard kinds of analysis.
Peroni: It does. Our portfolios generally have a low correlation to portfolios that are quantitatively or fundamentally derived. Also, our portfolios are unbiased; we do not depend on company management for information. We’re not coming to market with any pre-notions that because oil is at $82 or interest rates are near 0.0%, sectors should perform in a certain way. We do not rely on past history exclusively in forming a market outlook – we look at individual stocks on an ongoing basis and look for subtle changes in the stock’s historical behavior to glean whether there are meaningful shifts in the market or whether they are simply reinforcing ongoing trends.
Forbes: Terrific. Looking forward to hearing your thoughts.
Peroni: There’s much consternation that this will be another year to sell in May and go away. There is certainly a lot of evidence in the daily headline news, particularly concerning Europe,China andIndia, that would seem to indicate that the conventional wisdom will be right. We consider, however, that the market is highly oversold at this juncture. In fact, a recent Merrill Lynch report cited that sentiment was actually at its most negative levels since 1997.
Considering the gravity of that comment, and given that it does mesh well with what we are seeing technically, in terms of very oversold price behavior, good accumulation trends on a non-institutional basis and good continuity of leadership – that is, the leadership that was evident from the start of this cycle in 2002 was also prominent in the recovery following the 2007/2008 bear market and much the same leadership that we see in the market now.
We would make the case here that continuity of leadership is important, and that the 2007/2008 bear market was not a conventional bear market because it didn’t cause a sea change in leadership or usher in an entirely new economic cycle as bear markets have done historically.
Sentiment is so negative and we are repeatedly reacting to recycling worries about Europe. Any kind of good news this year – whether it be fiscal, monetary or political – could spur a very considerable rally.
The Dow did break below its 200-day moving average for the first time in six months, but it quickly recovered from that area and bounced back up to the 12,600 area. I think the recent weakness might have addressed some of the near-term selling and the reaction to the latest headline news with respect to Spain, Italy and Greece.
We are optimistic that with so much fear in the market and with the market having already corrected about 10%, that the risk to reward opportunities are improving.  The market is tightly wound like a spring and could react very significantly to good news.  I think we are going to first see this play out in terms of sector improvements, and then I think the broader market will follow along.
Forbes: That is encouraging. Against that background, do you have some particular investments that you’re suggesting at this point?
Peroni: We do. We continue to like the agriculture story. We think it is an enduring longer-term story with a number of the components in that area showing attractive relative strength.  We like companies like CF Industries (NYSE:CF), Agrium (NYSE:AGU) and Monsanto (NYSE:MON).
We also like the technology story. As you would expect with this level of general market volatility, technology moves to extremes.  I believe the sector is approaching oversold extreme levels. So companies like Alliance Data Systems (NYSE:ADS) and IBM (NYSE:IBM) look attractive, as does Apple (NASDAQ:AAPL). Apple has corrected considerably and has recently tested support.
Another area that we like is consumer discretionary. In that regard, we particularly like some of these sports-line companies, such as Under Armour (NYSE:UA) and Nike (NYSE:NKE).
Forbes: Sounds like a fairly broadly group of stocks.
Peroni: Well it is a pretty broad-based advance – this is not a micro-thematic advance. That is probably because of the great levels of liquidity due to the Fed’s accommodating policy. The Fed’s transparency takes a lot of monetary uncertainty out of the mix.
I’ll just mention one other area, and that is health care. Our father’s idea of health care was skewed towards defensive growth. Today it is much different – it is much more growth focused. There is a good sampling of stocks from the big-cap pharmas like Pfizer (NYSE: PFE), for instance, to Edwards Life Sciences (NYSE:EW), Laboratory Corp ofAmerica(NYSE:LH) and some of the generics, like West Pharmaceutical (NYSE:WST).
Forbes: Considering all of the dire things that have been in the news, it seems like some hopeful opportunities.
Peroni: Well with the dire headlines, one would think that the market should be hundreds of points, if not thousands of points, below where it is today. But I think the underlying support for the market is the direction of interest rates and company earnings as they compare to Wall Street expectations. We have extremely low interest rates right now along with the transparency of the Fed’s assurance that rates are not likely to rise any time soon. And, earnings are doing quite well relative to Street expectations. These two factors are providing underlying support for the market. I think there is a valuation watermark here for the market very close to the 12,000 level.
Forbes: Sounds very encouraging indeed for those who are reading this to have some courage about the long term rather than looking just at the immediate future. I appreciate it.
Peroni: I appreciate the opportunity. Thank you, Wally.
Original Article Here

No comments:

Post a Comment

LinkWithin

Related Posts Plugin for WordPress, Blogger...